Current Concepts in Gastric Signet Ring Cell Carcinoma

Ghoorun, Roshan Ara; Liao, Yi Jcn

doi:10.21767/2386-5180.100029

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, targeting tumor cells with loss of E-cadherin due to epithelial mesenchymal transition (EMT), which plays a central role in the loss of cohesiveness and increased chances of peritoneal dissemination in SRC cancers, is an interesting area of research in this subgroup of patients, which may eventually help improving their prognosis (89).…”

Section: Signet Ring Subtype Of Gastric Cancermentioning

confidence: 99%

Gastric Cancer With Peritoneal Metastasis—A Comprehensive Review of Current Intraperitoneal Treatment Modalities

Prabhu¹,

Mishra²,

Brandl

et al. 2022

Front. Oncol.

View full text Add to dashboard Cite

The treatment of patients with peritoneal metastasis from gastric cancer continues to evolve. With various forms of intraperitoneal drug delivery available, it is now possible to reach the sites of peritoneal metastases, which were otherwise sub-optimally covered by systemic chemotherapy, owing to the blood peritoneal barrier. We conducted a narrative review based on an extensive literature research, highlighting the current available intraperitoneal treatment options, which resulted in improved survival in well-selected patients of peritoneally metastasized gastric cancer. Intraperitoneal chemotherapy showed promising results in four different treatment modalities: prophylactic, neoadjuvant, adjuvant, and palliative. It is now possible to choose the type of intraperitoneal treatment/s in combination with systemic treatment/s, depending on patients’ general condition and peritoneal disease burden, thus providing individualized treatment to these patients. Randomized controlled trials for the different treatment modalities were mainly conducted in Asia and lack further validation in the other parts of the world. Most recent application tools, such as pressurized intraperitoneal aerosol chemotherapy, seem promising and need to pass the ongoing clinical trials.

show abstract

Section: Signet Ring Subtype Of Gastric Cancermentioning

confidence: 99%